Assetmark, Inc Veracyte, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 2,744 shares of VCYT stock, worth $98,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,744

Previous 20,973 86.92%

Holding current value

$98,619

Previous $454,000 79.52%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$21.0 - $35.25 $382,809 - $642,572	-18,229 Reduced 86.92%	2,744 $93,000
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $117,705 - $146,975	6,241 Added 42.36%	20,973 $454,000
Q1 2024 May 06, 2024	BUY	$21.0 - $29.1 $55,608 - $77,056	2,648 Added 21.91%	14,732 $326,000
Q4 2023 Feb 09, 2024	BUY	$19.72 - $28.68 $69,236 - $100,695	3,511 Added 40.95%	12,084 $332,000
Q3 2023 Oct 27, 2023	BUY	$22.33 - $29.92 $27,666 - $37,070	1,239 Added 16.89%	8,573 $191,000
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $26,598 - $34,250	1,269 Added 20.92%	7,334 $186,000
Q1 2023 May 05, 2023	BUY	$20.58 - $27.89 $14,385 - $19,495	699 Added 13.03%	6,065 $135,000
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $23,745 - $46,436	1,551 Added 40.66%	5,366 $127,000
Q3 2022 Nov 01, 2022	BUY	$16.58 - $27.9 $20,211 - $34,010	1,219 Added 46.96%	3,815 $63,000
Q2 2022 Aug 03, 2022	BUY	$15.45 - $29.52 $19,034 - $36,368	1,232 Added 90.32%	2,596 $52,000
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $7,744 - $15,006	353 Added 34.92%	1,364 $38,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $1,660 - $2,474	46 Added 4.77%	1,011 $42,000
Q4 2020 Feb 10, 2021	SELL	$32.49 - $61.88 $15,757 - $30,011	-485 Reduced 33.45%	965 $47,000
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $4,839 - $9,051	300 Added 26.09%	1,450 $35,000
Q4 2019 Feb 11, 2020	BUY	$20.78 - $29.99 $23,897 - $34,488	1,150 New	1,150 $32,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.57B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account